NSE filing, NSE: FERMENTA. Summary written from the filing by ALFA Finder's alert engine.
Fermenta Biotech Ltd: key numbers
- Share price
- ₹428.60
- Market cap
- ₹1,261 Cr
- Revenue (annual)
- ₹525.4 Cr
- Net profit (annual)
- ₹71.77 Cr
- P/E (TTM)
- 20.9×Sector 37.9×
- Promoter holding
- 60.12%-3.97% QoQ
- FII holding
- 1.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Fermenta Biotech Ltd
All →Fermenta Biotech Results Update
Fermenta Biotech reported H1FY27 consolidated revenue of Rs. 261.9 Crore, a 7% YoY decline. Profit after tax fell 52% to Rs. 18.9 Crore, impacted by lower animal nutrition pricing.
- Value
- ₹261.9 Cr
Fermenta Biotech Q2 FY27 Results: Net Profit ₹9.4 Cr, Down 47.8% YoY
Fermenta Biotech Ltd reported revenue from operations of ₹132.7 Cr (+1.9% YoY) and net profit of ₹9.4 Cr (-47.8% YoY) for Q2 FY27.
- Key figure
- Net profit ₹9.4 Cr · -47.8% YoY
Fermenta Biotech Board Meeting Date
Fermenta Biotech schedules a board meeting on November 5, 2026 to approve unaudited quarterly and half-year results. The trading window stays closed until 48 hours after results.
Fermenta Biotech Other Announcement
Fermenta Biotech Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Fermenta Biotech Promoter Selling
Fermenta Biotech Limited promoter Preeti Thakkar sold 11,65,938 equity shares (3.96%) in the open market. Her shareholding decreased from 7.61% to 3.65% following the transaction.
Fermenta Biotech Promoter Selling: ₹55.34 Cr
Fermenta Biotech Ltd promoter Preeti Thakkar sold 11,65,938 equity shares via open market sale. The transaction valued at ₹55.34 Crore reduced her stake from 7.61% to 3.65%.
- Value
- ₹55.34 Cr
Other merger & restructuring announcements
All →Thomas Cook (India) Merger & Restructuring
Thomas Cook (India) Ltd announced that the NCLT Mumbai Bench has issued directions regarding its composite scheme of arrangement. The scheme involves demergers and amalgamations with Sterling Holiday Resorts and other group entities.
Narayana Hrudayalaya Merger & Restructuring
Narayana Hrudayalaya's NCLT Bengaluru bench sanctioned the demerger of clinical services from its subsidiary NH Integrated Care. Order uploaded today; effectiveness awaits certified copy filings.
Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr